Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-854-1 | CAS number: 100-46-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Based on its physico-chemical characteristics, Benzylamine (CAS No. 100-46-9) is considered to be bioavailable after oral and dermal absorption. Absorption after inhalation of Benzylamine is expected to be unlikely due to a lack of quantitative exposure or moderate. Following uptake the compound can be distributed through the body thereby a pronounced metabolism is not expected. It is known that Benzylamine and its metabolites will be excreted rapidly via the urine.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 25
- Absorption rate - inhalation (%):
- 100
Additional information
In line with chapter R.7 c (ECHA, 2012) the main toxicokinetic properties of Benzylamine are assessed on the basis of its physico-chemical properties and with special regard to the results of the standard toxicity studies performed with this substance. Specific toxicokinetics or dermal absorption studies are not available for the substance.
1. Relevant physico-chemical properties of Benzylamine
Moleculare weight: 107,16 g/mol
logPow: 1 (at 25 °C, pH 9.8 - 10.4)
Water solubility: Miscible with water.
Vapour pressure: 0.06 hPa (20°C)
Boiling point: 185 °C (no data available for the atm. pressure)
Hydrolysis: No data available.
Surface tension: Based on chemical structure, no surface activity is predicted.
Particle size: Substance is a liquid.
2. Absorption:
Based on its low molecular weight, moderate logPow and relatively high water solubility Benzylamine is likely to be absorbed in the GI tract. The moderate logPow value of 1 (at 25 °C, pH 9.8 - 10.4) indicates that the substance is lipophilic, i.e.in the range between -1 and 4, and will thus diffuse well across plasma membranes. In addition, gastrointestinal absorption of Benzylamine is considered to be triggered by passage through aqueous membrane pores or carriage with the bulk passage of water, which is favoured for small (molecular weight < 200 g/mol), water soluble substances. It is unclear whether an active transport for Benzylamine exists. Overall, quantitative gastrointestinal absorption is expected for Benzylamine, based on its physicochemical properties. These assumptions are supported by acute oral toxicity studies (BASF AG, 1971 and Bayer AG, 1977), where death in treated animals was observed as well as clinical signs like sedation, respiratory disorders and tonical cramps. This provides a clear indication for systemic availability after gastrointestinal absorption.)
For dermal absorption a substance must be sufficiently lipophilic to cross the stratum corneum. Furthermore, the substance must be adequately soluble in water to partition form the stratum corneum into the epidermis. Since Benzylamine showed a log Pow of 1 and a high water solubility, dermal absorption is most likely. This assumption is supported by the fact that Benzylamine is corrosive to the skin (BASF AG, 1971 and Bayer AG, 1977), which may enhance the penetration through the skin. The ability of Benzylamine to penetrate through the skin barrier was shown in an acute dermal toxicity study (Bayer AG, 1977) performed on rats. During this study mortality and clinical signs of systemic toxicity were observed.
With a log Pow value between -1 and 4 and in view of the results obtained in an acute inhalation study where clinical signs on mucous membranes occured (BASF AG, 1971), Benzylamine is considered to be absorbed directly across the respiratory tract epithelium by passive diffusion when its vapour or particles reach the alveolar regions of the lungs. However, based on the low volatility and the high boiling point exhibited by Benzylamine, generally only low amounts of the substance will be available for inhalation under ambient conditions.
3. Distribution/Metabolism:
Benzylamine will be metabolized to benzoic acid, which forms via glycine conjugation hippuric acid, the main metabolite of Benzylamine (Wood et al., 1978; Al-Ani et al., 1979; Mutlib et al., 2002).
Generally, metabolism will render a xenobiotic molecule more polar and harmless, leading to fast and quantitative excretion. For Benzylamine, no conversion into a metabolite that was more cytotoxic or more genotoxic than the parent substance was noted when comparing in vitro test results with metabolic activation to in vitro test results without metabolic activation system (genetic toxicity tests). Based on this, a clear indication is given that the formation of reactive metabolites in vivo is unlikely.
4. Excretion:
Benzylamine will be rapidly excreted with the urine as the molecule is good water soluble with a low molecular weight of 107.16 g/mol.
Excretion studies in humans showed that Benzylamine will extremely rapidly be metabolised and excreted (> 90%) as hippuric acid in between hours in humans (Wood et al., 1978, Al-Ani et al., 1979) and rats (Mutlib et al., 2002).
Substances with log Pow of 3 or less are unlikely to accumulate with the repeated intermittent exposure pattern normally encountered in the workplace but may accumulate if exposures are continuous. Based on its log Pow of 1 (at 20 °C, pH 9.8 – 10.4), the good water solubility and the data from human excretion studies, it can be ruled out that the test substance will not accumulate in the human body under continuous exposure.
5. Generic absorption rates
Based on the above information and due to the fact that there are no specific toxicokinetic data available the generic values of 100 % for oral and inhalation absorption as well as 25 % for dermal absorption were established.
Reference
- ECHA (2012). Guidance on information requirements and chemical safety assessment, chapter R.7c: Endpoint specific guidance. ECHA-12-6-23-EN.R.7.12 Guidance on Toxicokinetics.
- EFSA (2012). Guidance on dermal adsorption. EFSA Journal: 10 (4) 2665
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.